Literature DB >> 7533766

Specificity in recognition of phosphopeptides by src-homology 2 domains.

L C Cantley1, Z Songyang.   

Abstract

SH2 domains and SH3 domains, found in a number of protein-tyrosine kinases and substrates of protein-tyrosine kinases, provide specificity in downstream signaling. Both of these domains bind to relatively short linear sequences of peptides to provide specific interactions between proteins. The SH2 domains directly bind to phosphotyrosine residues of proteins in a specific sequence context. We have devised a phosphopeptide library technique that allows us to rapidly determine the sequence specificity of individual SH2 domains on the basis of amino acids selected at position +1, +2 and +3 C-terminal of the phosphotyrosine. The optimal motif for 22 distinct SH2 domains has been determined and used to predict likely sites of in vivo interaction. A second phosphopeptide library was devised in which the amino acids N-terminal of the phosphotyrosine were also varied. The residues N-terminal of phosphotyrosine had little influence on binding to the N-SH2 domain of the 85 kDa subunit of phosphoinositide 3-kinase. These results indicate that for this SH2 domain, specificity is determined by sequences carboxy-terminal of the phosphotyrosine moiety. Knowledge of the specificity of SH2 domains allows predictions about likely downstream targets on the basis of primary sequence of proteins. Some of these predictions will be discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7533766     DOI: 10.1242/jcs.1994.supplement_18.18

Source DB:  PubMed          Journal:  J Cell Sci Suppl        ISSN: 0269-3518


  18 in total

1.  Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus.

Authors:  B Damania; M DeMaria; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  SH2 domains recognize contextual peptide sequence information to determine selectivity.

Authors:  Bernard A Liu; Karl Jablonowski; Eshana E Shah; Brett W Engelmann; Richard B Jones; Piers D Nash
Journal:  Mol Cell Proteomics       Date:  2010-07-13       Impact factor: 5.911

Review 3.  Integrin function in breast carcinoma progression.

Authors:  L M Shaw
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

4.  Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Authors:  L M Shaw
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  PhosphoBase: a database of phosphorylation sites.

Authors:  N Blom; A Kreegipuu; S Brunak
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

Review 6.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

Review 7.  Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance.

Authors:  Marcia N Paddock; Seth J Field; Lewis C Cantley
Journal:  J Lipid Res       Date:  2019-02-04       Impact factor: 5.922

8.  Dynamics and mechanism of p130Cas localization to focal adhesions.

Authors:  Dominique M Donato; Larisa M Ryzhova; Leslie M Meenderink; Irina Kaverina; Steven K Hanks
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

9.  Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.

Authors:  P J Ruest; N Y Shin; T R Polte; X Zhang; S K Hanks
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Authors:  Mark Rovedo; Richard Longnecker
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.